UNSPSC 51172833: Hydrogen peroxide/sodium bicarbonate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR500. This VA Drug Class (OR500) classifies this compound as belonging to the group MOUTHWASHES.

UNSPSC 51172833 Hydrogen peroxide/sodium bicarbonate is a Commodity code that in practice captures water treatment and facility maintenance chemicals supplied on contract to state and local government operations. Recent solicitations under this code involve public works departments and multistate cooperative purchasing alliances procuring chemicals for water treatment, utility facilities, and pharmaceutical supply chains — products that must meet DOT, OSHA, EPA, and FDA compliance standards, arrive on fixed delivery schedules with emergency-response capability, and come from vendors maintaining hazardous-materials transportation credentials and appropriate insurance. The issuing bodies include county public works operations (Orange County, California) and state-administered cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, coordinating across participating state and local government facilities).

Activity under this code spans California and Minnesota, with at least one multistate cooperative (MMCAP) serving participating jurisdictions in Oregon and elsewhere. Representative recent opportunities include the County of Orange, OC Public Works IFB 0803008401RE, closed March 27, 2026, seeking supply and delivery of sodium hypochlorite and sulfuric acid on a five-year contract with standard ten-working-day delivery and 24-hour emergency capability, FOB to its Santa Ana facility, with preference set-asides for certified Orange County Local Small Businesses and Disabled Veteran Business Enterprises receiving five percent and eight percent deduction preferences; and the Minnesota Department of Administration's MMCAP RFP S1070000015802, due March 26, 2026, establishing multistate contracts for generic pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026, with pricing weighted 75 percent and requiring cGMP certification and Drug Supply Chain Security Act compliance. No specific budget or award values are disclosed in either solicitation.